Evidence map›Paper›PMID 39023777›Full record

ArticleEJNMMI research2024

[

Kim M Pabst, Lukas Kessler, Justin Ferdinandus, Rainer Hamacher, Timo Bartel, Jens T Siveke, Michael Nader, Tim Brandenburg, Mélanie Desaulniers, Ken Herrmann and 1 more

Abstract read
In one paragraph

Article in EJNMMI research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kim M PabstDepartment of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany. kim.pabst@uk-essen.de.ORCID http://orcid.org/0000-0002-9234-0795
Lukas KesslerGerman Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Justin FerdinandusDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
Rainer HamacherGerman Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Timo BartelDepartment of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Jens T SivekeGerman Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Michael NaderDepartment of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Tim BrandenburgGerman Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Mélanie DesaulniersDepartment of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Ken HerrmannDepartment of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.
Wolfgang P FendlerDepartment of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRadiolabelled fibroblast activation protein inhibitors (FAPIs) are becoming increasingly important for imaging various tumour diseases. However, it is essential to be aware of potential pitfalls. Here, we investigate FAP expression in the thyroid gland in autoimmune thyroiditis (AIT).

methodsAIT patients with pathological thyroid uptake on [

resultsBetween September 2019 and July 2021, 6 patients presented with a visually increased thyroid uptake and TBR on [

conclusionPatients with AIT show higher thyroid uptake on [

Identifiers

PMID39023777
PMCPMC11258103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.